XML 38 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Equity Incentive Plan (Tables)
6 Months Ended
Jun. 30, 2023
Equity Incentive Plan [Abstract]  
Schedule of Share-Based Compensation Expense The Company recorded share-based compensation expense in the following expense categories in the condensed consolidated statements of operations and comprehensive loss for the six months ended June 30, 2023 and 2022
Stock Options & SARs   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
(in thousands)  2023   2022   2023   2022 
General and administrative  $277   $344   $511   $654 
Sales and marketing   64    42    123    70 
Research and development   93    81    184    146 
Cost of revenues   27    24    53    45 
   $461   $491   $871   $915 
RSUs  Three Months Ended
June 30,
   Six Months Ended
June 30,
 
(in thousands)  2023   2022   2023   2022 
General and administrative  $104   $
—
   $227   $
—
 
   $104   $
—
   $227   $
—
 
Schedule of Weighted Average Assumptions For the six months ended June 30, 2023 and 2022, the fair value of options granted was estimated using a Black-Scholes option pricing model with the following weighted average assumptions
   Six Months Ended
June 30,
 
   2023   2022 
Expected term (in years)   5.9    5.9 
Expected volatility   57.1%   54.4%
Risk-free rate   3.9%   1.9%
Dividend rate   
—
    
—
 
Schedule of Stock Option Activity The following table summarizes stock option activity under the 2020 Plan for the six months ended June 30, 2023
Stock Option & SARs  Number of
Shares
under
Equity
Plan
   Weighted-
Average
Exercise
Price per
Option
   Weighted-
Average
Remaining
Contractual
Life
(in years)
 
Outstanding at December 31, 2022   8,234,823   $1.82    7.7 
Granted   1,681,946   $2.00      
Exercised   (216,416)  $1.22      
Forfeited and expired   (137,732)  $2.03      
Outstanding at June 30, 2023   9,562,621   $1.91    7.7 
Exercisable at June 30, 2023   5,572,830   $1.55    6.9 
Vested and expected to vest at June 30, 2023   9,562,621   $1.91    7.7 
RSUs  Number of
Shares under
Equity Plan
   Weighted
Average
Grant Date
Fair Value
 
Outstanding at December 31, 2022   263,155   $1.90 
Granted   
—
   $
—
 
Exercised   
—
   $
—
 
Forfeited and expired   
—
   $
—
 
Outstanding at June 30, 2023   263,155   $1.90